Related references
Note: Only part of the references are listed.Mannose-functionalized solid lipid nanoparticles are effective in targeting alveolar macrophages
Ana Costa et al.
EUROPEAN JOURNAL OF PHARMACEUTICAL SCIENCES (2018)
Mucoadhesive chitosan-coated solid lipid nanoparticles for better management of tuberculosis
Alexandre C. C. Vieira et al.
INTERNATIONAL JOURNAL OF PHARMACEUTICS (2018)
Chitosan and Its Derivatives for Application in Mucoadhesive Drug Delivery Systems
Twana Mohammed M. Ways et al.
POLYMERS (2018)
Influence of silver content on rifampicin adsorptivity for magnetite/Ag/rifampicin nanoparticles
Olena Ivashchenko et al.
NANOTECHNOLOGY (2017)
Chitosan-coupled solid lipid nanoparticles: Tuning nanostructure and mucoadhesion
Giuseppina Sandri et al.
EUROPEAN JOURNAL OF PHARMACEUTICS AND BIOPHARMACEUTICS (2017)
Nebulized solid lipid nanoparticles for the potential treatment of pulmonary hypertension via targeted delivery of phosphodiesterase-5-inhibitor
Shaimaa Makled et al.
INTERNATIONAL JOURNAL OF PHARMACEUTICS (2017)
The Macrophage: A Disputed Fortress in the Battle against Mycobacterium tuberculosis
Christophe J. Queval et al.
FRONTIERS IN MICROBIOLOGY (2017)
Rifampicin loaded chitosan nanoparticle dry powder presents an improved therapeutic approach for alveolar tuberculosis
Tejal Rawal et al.
COLLOIDS AND SURFACES B-BIOINTERFACES (2017)
The formulation of nanomedicines for treating tuberculosis
Ana Costa et al.
ADVANCED DRUG DELIVERY REVIEWS (2016)
Solid lipid nanoparticles coated with cross-linked polymeric double layer for oral delivery of curcumin
Taoran Wang et al.
COLLOIDS AND SURFACES B-BIOINTERFACES (2016)
Mucoadhesive vs. mucopenetrating particulate drug delivery
Kesinee Netsomboon et al.
EUROPEAN JOURNAL OF PHARMACEUTICS AND BIOPHARMACEUTICS (2016)
Chitosan nanoparticles in drug therapy of infectious and inflammatory diseases
P. Rajitha et al.
EXPERT OPINION ON DRUG DELIVERY (2016)
Development, characterization, and in vivo assessment of mucoadhesive nanoparticles containing fluconazole for the local treatment of oral candidiasis
Seda Rencber et al.
INTERNATIONAL JOURNAL OF NANOMEDICINE (2016)
Design of a nanostructured lipid carrier intended to improve the treatment of tuberculosis
Marina Pinheiro et al.
DRUG DESIGN DEVELOPMENT AND THERAPY (2016)
Potential advantages of a novel chitosan-N-acetylcysteine surface modified nanostructured lipid carrier on the performance of ophthalmic delivery of curcumin
Dandan Liu et al.
SCIENTIFIC REPORTS (2016)
Improved mucoadhesion and cell uptake of chitosan and chitosan oligosaccharide surface-modified polymer nanoparticles for mucosal delivery of proteins
Sathish Dyawanapelly et al.
DRUG DELIVERY AND TRANSLATIONAL RESEARCH (2016)
Solid lipid nanoparticles for oral drug delivery: Chitosan coating improves stability, controlled delivery, mucoadhesion and cellular uptake
Yangchao Luo et al.
CARBOHYDRATE POLYMERS (2015)
Nano-carrier systems: Strategies to overcome the mucus gel barrier
S. Duennhaupt et al.
EUROPEAN JOURNAL OF PHARMACEUTICS AND BIOPHARMACEUTICS (2015)
Nanoparticle-Mediated Pulmonary Drug Delivery: A Review
Mukta Paranjpe et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2014)
Evaluation of the effect of rifampicin on the biophysical properties of membranes: Significance for therapeutic and side effects
Marina Pinheiro et al.
INTERNATIONAL JOURNAL OF PHARMACEUTICS (2014)
Advances in chitosan-based drug delivery vehicles
Liming Hu et al.
NANOSCALE (2013)
Freeze-drying of nanostructure lipid carriers by different carbohydrate polymers used as cryoprotectants
Jaleh Varshosaz et al.
CARBOHYDRATE POLYMERS (2012)
Effect of chitosan coating in overcoming the phagocytosis of insulin loaded solid lipid nanoparticles by mononuclear phagocyte system
Bruno Sarmento et al.
CARBOHYDRATE POLYMERS (2011)
Nanostructured lipid carrier (NLC) coated with Chitosan Oligosaccharides and its potential use in ocular drug delivery system
Qiuhua Luo et al.
INTERNATIONAL JOURNAL OF PHARMACEUTICS (2011)
Particle engineering for pulmonary drug delivery
Albert H. L. Chow et al.
PHARMACEUTICAL RESEARCH (2007)
Transport of proteins and peptides across human cultured alveolar A549 cell monolayer
ZY Wang et al.
INTERNATIONAL JOURNAL OF PHARMACEUTICS (2004)
Nanosuspensions as particulate drug formulations in therapy Rationale for development and what we can expect for the future
RH Muller et al.
ADVANCED DRUG DELIVERY REVIEWS (2001)
Share Paper
